跳至主要内容
临床试验/EUCTR2011-005360-22-FI
EUCTR2011-005360-22-FI进行中(未招募)1 期

Does melatonin (CircadinR) worsen glucose tolerance in individuals with at (rs10830963) variant in the melatonin receptor 1B (MTNR1B) gene?

Vasa HVC0 个研究点目标入组 60 人开始时间: 2012年2月1日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • known genotype for MTNR1B, age 18-75 years, health individual
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Diabetes, positive GAD antibodies, severe hypertension, glaukoma, coronary heart disease or arrhytmia, ventricle or duodenal ulcer, psychosis or severe psychiatric disase, severe sleep disorder, use of alpha or betaadrenerg blockers, creatinine >130, liver enzymes (ASAT, ALAT, ALP, GT, bilirubin) > 3 times normal, participation in another study, allergy to melatonin or capsules used

研究者

发起方
Vasa HVC

相似试验